100 years ago doctors had little credibility.  A education reformer's report remarkably reformed medical education and physicians' professionalism.  In the last thirty years this credibility has been eroded by financial ties between doctors and the drug companies.  Is it time for another Flexner Report. […] It's not enough to have doctors' payments from drug companies listed on some website. In every waiting room, patients should be able to read clear signs indicating doctors' payments received from companies and the specific drugs and products involved. In the long term medical research and academia must find a better way to separate their work from their sponsors' money. A general research fund of drug company money directed by an independent board has been suggested but seems unlikely given the profit driven priorities of the drug industry.